Mycophenolic acid (MPA) is one of many effective immunosuppressive drugs. However, MPA can induce cellular toxicity and impair cellular function in b-cells. To explore the effects of MPA and the relation between MPA and Trx-1, we used various methods, including an Illumina microarray, to identify the genes regulated during pancreatic b-cell death following MPA treatment. INS-1E cells (a pancreatic b-cell line) and isolated rat islets were treated with MPA for 12, 24, or 36 h, and subsequent microarray analysis showed that (Trx1) gene expression was significantly reduced by MPA. Further, Trx1 overexpression increased the cell viability, decreased the activations of c-jun N-terminal kinase (JNK) and caspase-3 by MPA, and attenuated ROS upregulation by MPA. Furthermore, siRNA knockdown of Trx1 increased MPA-induced cell death and the activations of p-JNK and caspase-3, and MPA significantly provoked the apoptosis of insulin-secreting cells via Trx1 downregulation. Our findings suggest that the prevention of Trx1 downregulation in response to MPA is critical for successful islet transplantation.
Subject Category: Experimental Medicine
Mycophenolic acid (MPA) is a potent, noncompetitive, reversible inhibitor of inosine-5 0 -monophosphate dehydrogenase (IMPDH), a key enzyme in the purine de novo synthetic pathway of guanosine nucleotides, 1, 2 and is widely used to prevent rejection after solid organ or islet transplantation. 3, 4 MPA effectively induces cell-cycle arrest in the late G 1 phase in lymphocytes and more potently inhibits lymphocyte proliferation than the proliferations of other cell types. 1, 5, 6 However, prolonged guanosine triphosphate (GTP) depletion induces the apoptosis of insulin-secreting cells. [6] [7] [8] Recently, it was suggested that MPA-mediated GTP depletion blocks DNA synthesis and induces b-cell death, 6, 7, 9, 10 but the mechanism responsible for MPA-induced b-cell death was not determined. We previously reported the specific depletion of GTP via the MPA-induced apoptosis of insulin-secreting cells (HIT-T15, RIN-5, INS-1E, and isolated rat islets) and also confirmed that co-treatment with GTP completely blocked MPA-induced cell death, which suggest that MPA inhibits de novo GTP synthesis and depletes GTP. 11, 12, 13 In addition, we identified genes expressionally altered during MPA-induced b-cell death and grouped these genes by cellular function. In particular, the expressions of 386 genes in INS-1E cells and of 234 genes in primary rat islet cells were found to be significantly altered by MPA as determined using an Illumina cDNA microarray. 13 Further, the expressions of some genes, such as, RhoGDI-a, Thioredoxin 1 (Trx1), Bcl2-related protein, and programmed cell death 2 (pdcd 2), are known to be closely related to MPA-induced b-cell death. 13, 14, 15 Trxs are small (B12 kDa) proteins that are found in several types of cells. These proteins operate in combination with Trx reductase and nicotinamide adenine dinucleotide phosphate (NADPH) as protein disulfide/dithiol reducing systems. 16, 17 In mammals, three members of the Trx family have been identified, namely, Trx1, Trx2 (the mitochondrially localized form), and Sptrx (sperm Trx, also designated p32TrxL). 18, 19 Trx1 is a multifunctional protein that is present in the extracellular milieu, cytoplasm, and nucleus, and has distinct roles in these environments. 20 The cellular activity of Trx1 is regulated by its total expression, localization (nucleus or cytosol) and protein-protein interactions, and by posttranslational modification. 21 In the extracellular environment, Trx1 exhibits chemokine-like activity, 22 whereas in the cytoplasm, by scavenging reactive oxygen species (ROS) and activating transcriptional factors, Trx1 is involved in a wide range of cellular responses, such as cell proliferation, apoptosis, and protection. [23] [24] [25] [26] The harmful effects of oxidative stress are considered to be especially relevant for b-cells because they express only low levels of antioxidant enzymes, such as superoxide dismutase (SOD, which converts superoxide radicals to H 2 O 2 ), catalase, cellular glutathione peroxidase (Gpx-1, which detoxifies H 2 O 2 ), and Trx. 27, 28 Further, the preventions of autoimmune and STZ-induced diabetes by Trx1 overexpression in b-cells suggest that Trx1 has important effects on b-cell destruction in type 1 diabetes (T1D) and on genetic susceptibility to T1D, 27, 29 and indicate that Trx1 has a critical role during b-cell death in T1D.
The objective of this study was to investigate the apoptotic effect of MPA on insulin-producing cells and to examine the role of Trx1 in this process. To explore these effects of MPA, we used various methods, including an Illumina microarray, to identify those genes regulated during pancreatic b-cell death following MPA treatment. In order to identify the effects of Trx1 downregulation on MPA-induced apoptosis, we observed the effects of Trx1 overexpression and knockdown on MPA treatment in rat INS-1E cells (an insulin-producing cell line). In addition, we examined the relationship between Trx1 expression and ROS generation during MPA-induced apoptosis in INS-1E cells.
Results
The identification of genes modulated by MPA using a microarray. Previously, we reported differentially expressed gene profiles during MPA-induced b-cell death. 13 For this analysis, INS-1E cells and isolated primary islets from rats were treated with 40 mM MPA for 24 h or 48 h. INS-1E cells and isolated islets were analyzed using an Illumina RatRef-12 Expression BeadChip. Previous analysis identified genes related to the apoptosis signaling pathway and showed that decreased RhoGDI-a to Rac1 binding increased Rac1 activity. 13, 30 Accumulating evidence indicates that Rac1 has a negative modulatory effect on the metabolic dysfunction of islet b-cells, especially with respect to the regulation of Nox activation. 31 Further, recent studies have implicated Nox in the constitutive generation of ROS following the long-term exposure of b-cells to various stimuli known to cause metabolic dysregulation. [32] [33] [34] In the present study, we grouped genes by molecular function and then focused on the oxidoreductase group, which accounted for many differentially expressed genes. It was found that 19 genes belonging to the oxidoreductase group were expressed at high values (4±twofold versus control cells) (Po0.05, n ¼ 4). In particular, this analysis confirmed that Trx1 gene expression was decreased by MPA (Table 1 ). These findings suggest that the downregulation of Trx1 by MPA in INS-1E cells is associated with MPA-induced b-cell apoptosis.
Changes in Trx1 expression during MPA-induced apoptosis. To confirm our microarray results, quantitative real-time PCR (qPCR) was performed after treating INS-1E cells with 10 mM MPA for 12, 24, or 36 h. In order to rescue GTP depletion after MPA treatment, 100 mM of GTP was co-treated into INS-1E cell for 36 h. Real-time PCR showed that mRNA expression levels decreased to 0.66 ± 0.03 at 12 h, 0.43 ± 0.09 at 24 h, and to 0.20 ± 0.10 at 36 h versus the untreated control (CTL) (Figure 1a) . Further, the gene expression level of Trx1 was time-dependently reduced by MPA. However, co-treatment with 10 mM MPA plus 100 mM GTP effectively prevented loss of Trx1 expression at 36 h (0.60 ± 0.01). These results were in line with our Genechip results. To quantify Trx1 protein expression under the same experimental conditions, we immunoblotted total protein lysates. The protein expression of Trx1 was found to decrease in INS-1E cells during MPA-induced cell death, but co-treatment with GTP significantly prevented this Trx1 protein deletion (Figure 1b) .
Primary rat islet cells correspond more closely than INS-1E cells to therapeutic islet transplants, and hence we evaluated the effects of MPA on rat islet cells and compared the mechanism of MPA-induced cell death in these primary cultures with that in the INS-1E cell line. Real-time PCR was performed after treating islet cells with 40 mM MPA for 12 h, Figure 1d ). Using immunohistochemistry, we confirmed that Trx1 protein expression was downregulated during apoptosis in primary rat islets treated with 40 mM MPA. To identify b-cells, islet cluster sections were stained for insulin. It is known that the cytoarchitectures of pancreatic islets are species dependent. In particular, rodent islets are characterized by a predominance of insulin-producing b-cells in the cores of islet clusters and by scarce alpha, delta, and PP cells in peripheries. 35, 36 As shown in Changes in Trx1 expression were closely associated with MAPK-dependent apoptosis. In earlier studies, we found that MPA induced apoptosis in several pancreatic b-cell lines via JNK activation, 12,13,37 and thus we investigated the effect of Trx1 expression on the MAPK signaling pathway. After treating INS-1E cells and the Trx1-overexpressing INS-1E cell line with 10 mM MPA for 12 h, 24 h, or 36 h, p-MKK4/7, p-JNK, and cleaved caspase-3 protein levels were measured by western blotting. p-MKK4/7 was observed at 12 h and its level was increased at 24 h. However, this increase was not observed at any time in Trx1-overexpressing cells (Figure 4a ). p-JNK protein levels were dramatically increased at 24 h and slightly more increased at 36 h versus untreated controls, but its levels were increased only at 36 h in Trx1-overexpressing cells (Figure 4b ). The expression of cleaved caspase-3 was markedly lower in Trx1-overexpressing cells than in INS-1E cells (Figure 4c) . Further, Trx1 knockdown increased the activations of MKK4/7, JNK, and caspase-3 (Supplementary data 1). These results show that Trx1 expression regulates MPA-induced apoptosis via an MAPK-dependent signaling pathway.
ROS level measurements in INS-1E cells treated with MPA. The key biological activities of Trx1 include antioxidative, antiapoptotic, and growth-stimulatory effects, which are attributable to its interactions with nuclear factor-kB (NF-kB), apoptosis signal regulating kinase-1 (ASK-1), and hypoxia-inducible factor-1. 24, 37, 38 The most distinctive role of Trx1 concerns the repair of proteins oxidized by reactive oxygen-containing intermediates. Therefore, we used DCF-DA to detect cellular ROS in INS-1E cells treated with MPA. Cellular ROS generation was observed by fluorescence microscopy after treating INS-1E and Trx1-overexpressing INS-1E cells with 10 mM MPA. As shown in Figure 5a , cellular Figure 2 The expression of Trx1 was diminished in the b-cells of isolated rat islets by MPA. Isolated rat islet clusters were treated with 40 mM MPA alone for 12, 24, or 36 h or co-treated with 40 mM MPA plus 100 mM GTP for 36 h. At the indicated times, islets were fixed in 4% paraformaldehyde and sectioned at 4-mm. Insulin (green) staining shows b-cell locations and population sizes in isolated rat islets. Trx1 (red) staining decreased time-dependently after treating b-cells with MPA, but this decrease was inhibited when GTP was co-treated (after 36 h of treatment). The bar graphs show numbers of insulin-stained cells (black bar), and Trx1 and insulin co-stained cells (gray dotted blocks). Cell numbers were counted in 3-4 images per experiment, and experiments were performed in triplicate. Values are means ± SEMs (***Po0.001) ROS increased during MPA-induced apoptosis, whereas ROS generation was obviously less in Trx1-overexpressing cells. To quantify intracellular ROS levels more precisely, we used fluorescence spectrophotometry. Intracellular ROS levels in INS-1E cells increased in a time-dependent manner after treatment with 10 mM MPA for 12 h, 24 h, or 36 h (by 104.3 ± 0.9%, 118.3 ± 9.8%, and 137.0 ± 8.7% of the untreated control levels, respectively). However, ROS generation in Trx1-overexpressing cells remained at the untreated control level at all times (99.7 ± 4.5%, 107.0±9.0%, and 110.3±4.3% of untreated controls, respectively) (Figure 5b ). These results show that Trx1 overexpression blocked ROS generation during MPAinduced b-cell apoptosis. 
Discussion
Although islet transplantation is more widely accessible and reproducible than pancreatic transplantation, it presents several issues in the clinical setting. In particular, transplants are susceptible to drug-induced toxicity and might be physiologically inadequate. MPA-induced b-cell toxicity can also affect islet graft survival, 6, 7 but the signal transduction mechanisms responsible for MPA-induced b-cell toxicity have not been elucidated. In the present study, we investigated the role of Trx1 in MPA-induced b-cell apoptosis. In particular, we examined (1) changes in Trx1 expression during MPAinduced apoptosis, (2) the effects of Trx1 overexpression and knockdown on the effects of MPA treatment in the rat insulin-producing cell line INS-1E, and (3) the relationship between Trx1 expression and ROS generation in INS-1E cells during MPA-induced apoptosis. This study has two major findings. First, it demonstrates that MPA reduces Trx1 expression at the protein and gene levels in INS-1E cells and in isolated rat islets. Second, it shows that cell viability is restored by Trx1 overexpression, therefore preventing MPAinduced apoptosis via the MAPK pathway and suppressing ROS generation in response to MPA. Using the microarray technique, we found that numerous genes could be involved in the death of insulin-secreting cells exposed to MPA. As described in the introduction, Trx1 is a candidate antiapoptotic gene in insulin-secreting cells 13 and probably exerts its antiapoptotic effect on the ischemic-reperfused hearts via its antioxidant and ASK-1 inhibitory effects. Further, treatment with Trx1 before reperfusion markedly inhibits p38 MAPK activity. 39 In addition to its activity as an oxidoreductase, recent in vitro studies have demonstrated that Trx1 directly interacts with and inhibits the activity of ASK-1, a mitogenactivated protein kinase that activates the proapoptotic kinases, MAPK, and JNK. 24, [40] [41] [42] In this study, we found that modulations of Trx1 expression affected b-cell viability and the MAPK pathway after MPA treatment. Together, our findings and those described above indicate that Trx1 is Hotta et al. 27 showed that Trx1 overexpression markedly reduced the incidence of diabetes but failed to prevent the development of insulitis. This result suggests that the autoimmune destruction of pancreatic b-cells in type 1 diabetes is at least partially mediated by reactive oxidative intermediates (ROIs) and that this mediation can be blocked by Trx1. 28 In the islet transplantation experiment, Trx-overexpressed islets showed better glycemic control and longer graft survival, indicating that Trx has a strong cytoprotective effect on islets. 29 These effects may reflect the multiple biological functions of Trx, which has both antioxidative and antiapoptotic activities. In the present study, Trx1 expression was inhibited by MPA, and the overexpression of Trx1 inhibited MPA-induced apoptosis by activating the JNK pathway, which suggests that pancreatic b-cell viability could be improved by Trx1 overexpression during MPA-induced apoptosis. In further studies, we suggest ASK-1 and TXNIP immunoassays be used to determine how MPA affects the expressions of these proteins, and that an additional study be undertaken to determine the nature of the relation between RhoGDI-a and Trx1, and the mechanism(s) responsible for regulating these genes.
Summarizing, we found MPA reduces the expression of Trx1 at the protein and gene levels, and that this downregulation leads to the apoptosis of insulin-secreting cells via the MKK4/7-JNK pathway. Further, our findings indicate Trx1 might mitigate MPA-induced islet cell death and indicate that further studies are needed to evaluate the effects of Trx1 modulation in transplant models.
Materials and Methods
Cells and culture reagents. Cells were maintained at 37 1C in a 5% CO 2 -humidified incubator. INS-1E insulinoma rat pancreatic b-cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum (FBS) (Gibco, Grand Island, NY, USA), 100 units/ml penicillin, and 100 mg/ml streptomycin, and cells that overexpressed Trx1 were grown in RPMI-1640 medium containing 10% FBS and 0.2 mg/ml G418.
Islet isolation and primary cell culture. The pancreas of a Lewis rat (250-350 g) was digested using collagenase P (Roche, Indianapolis, IN, USA), and the islets so obtained were purified using three different Histopaque (Sigma Chemical Co., St Louis, MO, USA) gradients. Islets were maintained in RPMI-1640 medium containing 10% FBS (Gibco), 100 units/ml penicillin, and 100 mg/ml streptomycin in a humidified 5% CO 2 atmosphere at 37 1C.
Illumina microarray gene analysis. Microarray analysis was performed using an Illumina RatRef-12 Expression BeadChip (Illumina, San Diego, CA, USA), according to the manufacturer's instructions (Macrogen, Seoul, Korea). Biotinylated cRNAs were prepared from 0.55 mg of total RNA using an Illumina Total Prep RNA Amplification Kit (Ambion, Austin, TX, USA). Following fragmentation, 0.75 mg of cRNA was hybridized to the Illumina RatRef-12 Expression BeadChip (Illumina). Arrays were scanned using an Illumina Bead Array Reader Confocal Scanner. Array data export processing and analysis were performed using Illumina BeadStudio v3.1.3 (Gene Expression Module v3.3.8, Stratagene, CA, USA).
Total RNA isolation. Following medium aspiration, INS-1E cells were lysed directly in culture dishes by adding TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Lysed samples were incubated for 5 min at room temperature and then mixed with chloroform in a tube by vortexing for 15 s. Tubes were centrifuged at 12 000 Â g for 15 min at 4 1C, and supernatants were transferred into new tubes containing isopropanol and then incubated at room temperature for 10 min. Samples were then centrifuged at 12 000 Â g for 10 min at 4 1C. The supernatants obtained were discarded and pellets were washed in 70% ethanol and lysed in RNase-free water.
RT-PCR and quantitative real-time PCR. Total RNA was reverse transcribed using oligo-dT and a M-MLV Reverse Transcriptase (Invitrogen) protocol, and PCR was performed using Bioneer Accupower PCR PreMix (Bioneer, Korea). Real-time PCR was performed using cDNA, a TaqMan probe, and Real-time PCR master mix (QPK-101, TOYOBO, Osaka) using the Taqman assay protocol. Transcript values and Ct values were normalized against GAPDH and expressed as fold differences versus controls. Fluorescence microscopy. Fluorescence microscopic images of fixed cells were captured using an Olympus IX71 fluorescence microscope equipped with a DP71 camera and DP-BSW Application software (Olympus Corporation, Tokyo, Japan).
Trx1 gene cloning. In vitro Trx1 transcription templates were amplified by PCR from INS-1E cDNA using 5 0 -TCCAATGTGGTGTTCCTTGA-3 0 (forward) and 5 0 -ACCAGAGAACTCCCCAACCT-3 0 (reverse). PCR products were cloned into mammalian and bacterial expression vectors using flanking restriction sites engineered into the PCR oligonucleotides. After subcloning cDNA into pcDNA 3.1 vector, the insert was fully sequenced using the dideoxy nucleotide chain termination method and Taq DNA polymerase. The vector was transfected into insulin-secreting cells over 2 h using 4 ml of Lipofectamine 2000 (Invitrogen) in 200 ml of serum-free culture medium. Cell viability analysis. Cell viabilities were determined using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Briefly, cells were seeded in a 24-well plate at a density of 2 Â 10 5 cells/well and treated with 10 mM of MPA (Sigma) for 12 h, 24 h, or 36 h at 37 1C. MTT solution was added to each well to a final concentration of 1 mg/ml and incubated for 1 h at 37 1C. The formazan crystals formed were dissolved in Detergent Reagent (Trevigen, Gaithersburg, MD, USA), and absorbance at 540 nm was measured using an ELISA plate reader (Molecular Devices, Palo Alto, CA, USA).
Measurement of intracellular ROS production. The peroxidesensitive fluorescent probe 2,7-dichlorodihydrofluorescein diacetate (DCF-DA; Molecular Probes, Carlsbad, CA, USA) was used to assess the generation of intracellular ROS. To observe intracellular ROS generation, treatment-naive INS-1E cells and cells overexpressing Trx1 were grown in six-well plates at a density of 7 Â 10 5 cells/well, treated with 10, 40, or 80 mM of MPA for 12, 24, or 36 h, incubated at 37 1C for 30 min in the dark in serum-free medium containing 5 mM DCF-DA, and washed three times with phosphate-buffered saline (PBS). Fluorescence microscopic images were captured using an OlympusIX71 fluorescence microscope (Olympus Corporation). To quantify ROS levels, treatment-naive INS-1E cells and cells over-expressing Trx1 were grown in 96-well plates at a density of 4 Â 10 4 cells/well, incubated with 10 mM DCF-DA at 37 1C for 30 min in the dark, and treated with 10mM MPA for 12, 24, or 36 h. Fluorescence was measured using a luminescence spectrophotometer (Perkin Elmer LS50B, Wellesley, USA) and at excitation and emission wavelengths of 485 and 530 nm, respectively. ROS levels were calculated as percentage increases versus untreated control levels.
Statistical analysis. Results are presented as means ± SEMs. One-way ANOVA and the post hoc Student's t-test were used to determine the significance of differences between means. Statistical significance was accepted for P-values of o0.05, and the analysis was conducted using GraphPad Prism software (GraphPad Software, Inc., CA, USA).
